Scientists successfully test 'breakthrough' vaccine for koala chlamydia
Australian scientists have successfully treated wild koalas for chlamydia, thanks to a "breakthrough" vaccine, AFP reports.
Microbiologists from the University of the Sunshine Coast in Queensland, Australia, spent five years creating the trial vaccine, which they have now successfully tested. The disease is "ravaging" Australia's koala population, AFP notes, but the new vaccine may be able to save the koalas that are left.
The scientists treated 30 koalas with the vaccine and studied their health alongside 30 unvaccinated koalas. The 30 vaccinated included both healthy koalas and those already infected with chlamydia. Among those vaccinated, koalas that were carrying the chlamydia strain didn't develop the disease, and those who showed chlamydia symptoms, such as eye infections, saw improvement as well.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Koalas are classified as a "vulnerable species," according to the Australian government. Recent estimates suggest there are as few as 43,000 koalas in the wild, but there were more than 10 million in the 18th century. The scientists hope to continue testing the trial vaccine, including the "possible vaccination of entire communities of koalas," AFP reports.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
-
Political cartoons for November 30Cartoons Sunday's political cartoons include the Saudi-China relationship, MAGA spelled wrong, and more
-
Rothermere’s Telegraph takeover: ‘a right-leaning media powerhouse’Talking Point Deal gives Daily Mail and General Trust more than 50% of circulation in the UK newspaper market
-
The US-Saudi relationship: too big to fail?Talking Point With the Saudis investing $1 trillion into the US, and Trump granting them ‘major non-Nato ally’ status, for now the two countries need each other
-
Blue Origin launches Mars probes in NASA debutSpeed Read The New Glenn rocket is carrying small twin spacecraft toward Mars as part of NASA’s Escapade mission
-
Dinosaurs were thriving before asteroid, study findsSpeed Read The dinosaurs would not have gone extinct if not for the asteroid
-
SpaceX breaks Starship losing streak in 10th testspeed read The Starship rocket's test flight was largely successful, deploying eight dummy satellites during its hour in space
-
Rabbits with 'horns' sighted across Coloradospeed read These creatures are infected with the 'mostly harmless' Shope papilloma virus
-
Lithium shows promise in Alzheimer's studySpeed Read Potential new treatments could use small amounts of the common metal
-
Scientists discover cause of massive sea star die-offSpeed Read A bacteria related to cholera has been found responsible for the deaths of more than 5 billion sea stars
-
'Thriving' ecosystem found 30,000 feet underseaSpeed Read Researchers discovered communities of creatures living in frigid, pitch-black waters under high pressure
-
New York plans first nuclear plant in 36 yearsSpeed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
